Featuring Cell & Gene Therapy companies from China, Taiwan, Korea, Japan, South Asia, SEA, and Australia! APAC Cell & Gene Therapy Market 2021 covers comprehensive information on parameters such as product pipeline, future expansion plans, technologies used, production capacity, temperature requirements, manufacturing capabilities, and SCM preferences. It also contains analysis on market growth, M&As, financial updates, upcoming facilities and more. It provides readers a closer look into companies such as Chugai, Tessa Therapeutics, Daewong Pharm, Eutilex, Carmine Therapeutics, Sumitomo Dainippon, Unicocell Biomed, JW Creagene, Takara Bio and more.
APAC Cell & Gene Therapy Market
$5,998 – $10,698
KEY TAKEAWAYS
- Insights on production processes, equipment, logistics and SCM services various BioPharmas and CMOs currently and plan to employ.
- Understand the facility expansion plans of key players in the APAC region.
- Identify potential clients who would be interested in your latest technology or service.
